CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease.

CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease. — المؤلف: Matutino, Adriana — Therapeutic advances in medical oncology 2018

المؤلف
Matutino, Adriana
النشر
Therapeutic advances in medical oncology 2018
الوصف
1758835918818346 p.